Ignite Creation Date:
2024-05-06 @ 1:18 AM
Last Modification Date:
2024-10-26 @ 11:01 AM
Study NCT ID:
NCT01772797
Status:
COMPLETED
Last Update Posted:
2020-12-19
First Post:
2013-01-17
Brief Title:
Phase Ib Study of LDK378 and AUY922 in ALK-rearranged Non-small Cell Lung Cancer
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Non-small Cell Lung Cancer |
| Anaplastic Lymphoma Kinase ALK |
Keywords:
| Name | View |
|---|---|
| anaplastic lymphoma kinase ALK-rearranged lung cancer non-small cell lung cancer | View |